Compound name
Necitumumab
Alt Name
Portrazza
IMC-11F8
Compound Image
Necitumumab.png
Approval Jurisdiction
2015 FDA 2015 EMA
Approved for clinical use
NSCLC
CAS
906805-06-9
Action
EGFR
Approved Drug List
1
Commercial Vendor
Eli Lilly
Reference
Reference 2